Calidi Biotherapeutics continues to advance its clinical-stage, off-the-shelf, virotherapies. With RTNova, the company is planning multi-modal systemic antitumor virotherapies that can disrupt tumor ...

The FDA has approved FoundationOne Liquid CDx as a companion diagnostic for patients with metastatic non–small cell lung ...

Calidi (CLDI) Biotherapeutics presented data at the International Oncolytic Virotherapy Conference and the Society for Immunotherapy of Cancer Annual Meeting to support the targeted capabilities of ...

At the April Sampson Cancer Center on Monday, Tom Uhlman shared his story as part of the Shine a Light on Lung Cancer ...

Linda Chavez was just 34 when she discovered she had advanced lung cancer, also called Metastatic Bronchial Carcinoma. A ...

Linda Chavez, 34, was diagnosed with Metastatic Bronchial Carcinoma, which has spread to her brain and bones. She regularly ...

Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

Certain characteristics of the COVID-19 infection were associated with possible tumor shrinkage in patients with metastatic sites of melanoma, lung, breast and colon cancers, an expert told CURE®.

Merck (MRK) stock gains as its subcutaneously delivered pembrolizumab meets key goals in Phase 3 trial against intravenous ...

After feedback from the FDA, the companies have voluntarily withdrawn the previous biologics licensing application for ...